Maine Revised Statutes Title 22 Sec. 2430 – Medical Use of Cannabis Fund established
Current as of: 2023 | Check for updates
|
Other versions
1. Fund established. The Medical Use of Cannabis Fund, referred to in this section as “the fund,” is established as an Other Special Revenue Funds account in the department for the purposes specified in this section.
[PL 2017, c. 409, Pt. E, §10 (AMD); PL 2021, c. 669, §5 (REV).]
Terms Used In Maine Revised Statutes Title 22 Sec. 2430
- Cannabis testing facility: means a public or private laboratory that:
A. See Maine Revised Statutes Title 22 Sec. 2422Caregiver: means a person or an assistant of that person that provides care for a qualifying patient in accordance with section 2423?A, subsection 2. See Maine Revised Statutes Title 22 Sec. 2422 Department: means the Department of Administrative and Financial Services. See Maine Revised Statutes Title 22 Sec. 2422 dispensary: means an entity registered under section 2425?A that acquires, possesses, cultivates, manufactures, delivers, transfers, transports, sells, supplies or dispenses cannabis plants or harvested cannabis or related supplies and educational materials to qualifying patients and the caregivers of those patients. See Maine Revised Statutes Title 22 Sec. 2422 Harvested cannabis: includes cannabis concentrate and cannabis products. See Maine Revised Statutes Title 22 Sec. 2422 manufacturing: means the production, blending, infusing, compounding or other preparation of cannabis concentrate and cannabis products, including, but not limited to, cannabis extraction or preparation by means of chemical synthesis. See Maine Revised Statutes Title 22 Sec. 2422 Medical use: means the acquisition, possession, cultivation, manufacture, use, delivery, transfer or transportation of cannabis or paraphernalia relating to the administration of cannabis to treat or alleviate a qualifying patient's medical diagnosis or symptoms for which a medical provider has provided the qualifying patient a written certification under this chapter. See Maine Revised Statutes Title 22 Sec. 2422 patient: means a person who has been a resident of the State for at least 30 days and who possesses a valid written certification regarding medical use of cannabis in accordance with section 2423?B. See Maine Revised Statutes Title 22 Sec. 2422 Year: means a calendar year, unless otherwise expressed. See Maine Revised Statutes Title 1 Sec. 72
2. Sources of fund. The State Controller shall credit to the fund:
A. All money received as a result of applications and reapplications for registration as a qualifying patient, caregiver, dispensary, manufacturing facility and cannabis testing facility; [PL 2017, c. 452, §19 (AMD); PL 2021, c. 669, §5 (REV).]
B. All money received as a result of applications and reapplications for registry identification cards for registered patients, caregivers, dispensaries and officers or directors or assistants of registered caregivers, dispensaries, manufacturing facilities and cannabis testing facilities; [PL 2017, c. 452, §20 (AMD); PL 2021, c. 669, §5 (REV).]
C. All penalties and fines assessed for violations of this chapter; [PL 2009, c. 631, §45 (NEW); PL 2009, c. 631, §51 (AFF).]
D. All money from any other source, whether public or private, designated for deposit into or credited to the fund; [PL 2019, c. 312, §2 (AMD).]
E. Interest earned or other investment income on balances in the fund; and [PL 2019, c. 312, §2 (AMD).]
F. All money received as a result of a reorganization of a registered dispensary operating as a nonprofit entity to a for-profit entity pursuant to section 2428, subsection 13, paragraph D. [PL 2019, c. 312, §3 (NEW).]
[PL 2019, c. 312, §§2, 3 (AMD); PL 2021, c. 669, §5 (REV).]
3. Uses of the fund. The fund may be used for expenses of the department to administer this chapter or for research in accordance with subsection 5, as allocated by the Legislature.
A. [PL 2021, c. 181, Pt. A, §2 (RP).]
B. [PL 2021, c. 181, Pt. A, §2 (RP).]
[PL 2021, c. 181, Pt. A, §2 (AMD).]
4. Review of fund balance. Beginning January 2018 and every 2 years thereafter, the department shall review the balance in the fund. If the balance in the fund exceeds $400,000, the department shall reduce the fees established under section 2425?A, subsection 10 for a 2-year period beginning with the calendar year following the review.
[PL 2017, c. 452, §22 (NEW).]
5. Medical cannabis research grant program established. The medical cannabis research grant program, referred to in this subsection as “the program,” is established within the department to provide grant money to support objective scientific research, including observational and clinical trials and existing research, on the efficacy of harvested cannabis as part of medical treatment and the health effects of harvested cannabis used as part of medical treatment. The program must be funded from the fund. The department shall adopt rules necessary to implement the program, including, but not limited to, required qualifications of persons conducting the research; determining the scientific merit and objectivity of a research proposal; criteria for determining the amount of program funds distributed; criteria for determining the duration of the research; procedures for soliciting research participants, including outreach to patients, and for obtaining the informed consent of participants; and reporting requirements for the results of the research and evaluation of the research results. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2?A, except that, beginning July 1, 2021, rules adopted pursuant to this subsection are major substantive rules as defined in Title 5, chapter 375, subchapter 2?A.
[PL 2021, c. 387, §11 (AMD); PL 2021, c. 669, §5 (REV).]
SECTION HISTORY
PL 2009, c. 631, §45 (NEW). PL 2009, c. 631, §51 (AFF). PL 2015, c. 475, §25 (AMD). PL 2017, c. 409, Pt. E, §10 (AMD). PL 2017, c. 452, §§19-22 (AMD). PL 2019, c. 312, §§2, 3 (AMD). PL 2019, c. 331, §31 (AMD). PL 2021, c. 181, Pt. A, §2 (AMD). PL 2021, c. 387, §11 (AMD). PL 2021, c. 669, §5 (REV).